Inscripta

inscripta.com

Inscripta is a pioneering company in the bioeconomy, leveraging its Geno Scaler™ platform and MAD7® nuclease to revolutionize biomanufacturing. Their Lean Bioengineering™ approach integrates Directed Evolution, CRISPR+, and Machine Learning, enabling faster, more cost-effective, and scalable solutions for strain engineering. By significantly reducing the time and cost associated with traditional methods, Inscripta positions itself as a leader in sustainable biomanufacturing, catering to a growing market that demands affordable and efficient biological products. The company's recent acquisitions further enhance its technological portfolio, solidifying its market position and traction in the industry.